De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase) as a Significant Prognostic Factor in Patients Undergoing Radical Cystectomy with Bladder Urothelial Carcinoma: A Propensity Score-Matched Study
Open Access
- 27 August 2019
- journal article
- research article
- Published by Wiley in Disease Markers
- Vol. 2019, 1-8
Abstract
Introduction. To investigate the correlation between preoperative De Ritis ratio (aspartate transaminase (AST)/alanine transaminase (ALT)) and postoperative outcome in patients with urothelial cell carcinoma (UC) treated with radical cystectomy.Materials and Methods. We analyzed the clinical and pathological data of 771 patients who underwent radical cystectomy for bladder UC. Patients were divided into two groups according to the optimal value of AST/ALT ratio. The effect of the AST/ALT ratio was analyzed using the Kaplan–Meier method and Cox regression hazard models for patients’ cancer-specific survival (CSS), overall survival (OS), and recurrence-free survival (RFS). In addition, propensity score matching of 1 : 1 was performed between the two groups.Results. Median follow-up was 84.0 (36–275) months. Mean age wasyears. According to the receiver operating characteristic (ROC) analysis, the optimal threshold of the AST/ALT ratio was 1.1. In Kaplan–Meier analyses, the high AST/ALT group showed worse outcomes in CSS and OS (all). Also, RFS () in the Cox regression models of clinical and pathological parameters was used to predict CSS, OS, and AST/ALT ratio (HR 2.15, 95% CI 1.23-3.73,) and pathological T stage (HR 4.80, 95% CI 1.19-19.28,). To predict OS and AST/ALT ratio (HR 2.05, 95% CI 1.65–2.56,), pathological T stage (HR 2.96, 95% CI 0.57–17.09,) and positive lymph node (HR 1.71, 95% CI 1.50–1.91,) were determined as independent prognostic factors.Conclusion. Preoperative AST/ALT ratio could be an independent prognostic factor in patients with UC treated with radical cystectomy.
Keywords
Funding Information
- Ministry of Education (2016R1A2B4011623)
This publication has 30 references indexed in Scilit:
- Defining and Treating the Spectrum of Intermediate Risk Nonmuscle Invasive Bladder CancerJournal of Urology, 2014
- A systematic review of data on biological variation for alanine aminotransferase, aspartate aminotransferase and γ-glutamyl transferaseClinical Chemistry and Laboratory Medicine (CCLM), 2013
- Modelling prognostic factors in advanced pancreatic cancerBritish Journal of Cancer, 2008
- Prognostic and diagnostic value of serum pseudocholinesterase, serum aspartate transaminase, and serum alinine transaminase in malignancies treated by radiotherapyJournal of Cancer Research and Therapeutics, 2008
- Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC TrialsEuropean Urology, 2006
- Metabolic classification of human rectal adenocarcinomas: a novel guideline for clinical oncologists?Journal of Cancer Research and Clinical Oncology, 2003
- Prognostic predictors in colorectal cancerDiseases of the Colon & Rectum, 1994
- Liver metastases from breast cancer: The relationship between clinical, biochemical and pathological features and survivalEuropean Journal of Cancer, 1990
- An enzymic test for the diagnosis of viral hepatitis: The transaminase serum activitiesClinica Chimica Acta, 1957
- TRANSAMINASE ACTIVITY IN HUMAN BLOODJournal of Clinical Investigation, 1955